Nunzia Pharmaceutical Company
NUNZ
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.40K | 5.10K | 5.00K | 100.00 | 500.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 24.90K | -- | -- | 4.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 35.40K | 29.90K | 5.00K | 100.00 | 4.50K |
|
|
|||||
| Total Current Assets | 35.40K | 29.90K | 5.00K | 100.00 | 4.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00 | -- | -- | -- |
| Total Assets | 35.40K | 29.90K | 5.00K | 5.10K | 9.50K |
|
|
|||||
| Total Accounts Payable | 43.30K | 7.40K | 4.90K | 1.90K | 11.20K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 183.30K | 140.00K | 132.40K | 97.40K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 86.50K |
| Total Other Current Liabilities | -- | -- | -- | -- | 86.50K |
| Total Current Liabilities | 226.70K | 147.30K | 137.30K | 99.30K | 97.70K |
|
|
|||||
| Total Current Liabilities | 226.70K | 147.30K | 137.30K | 99.30K | 97.70K |
| Long-Term Debt | -- | -- | -- | -- | 23.00K |
| Short-term Debt | 183.30K | 140.00K | 132.40K | 97.40K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 226.70K | 147.30K | 137.30K | 99.30K | 120.70K |
|
|
|||||
| Common Stock & APIC | 198.17M | 198.01M | 197.97M | 179.29M | 101.26M |
| Retained Earnings | -198.39M | -198.16M | -198.14M | -179.41M | -101.41M |
| Treasury Stock & Other | 31.70K | 31.70K | 31.70K | 31.70K | 31.70K |
| Total Common Equity | -191.30K | -117.40K | -132.30K | -94.20K | -111.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -191.30K | -117.40K | -132.30K | -94.20K | -111.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -191.30K | -117.40K | -132.30K | -94.20K | -111.20K |
|
|
|||||